Plasma TLR2 and TLR4 activators represent both gut-derived microbial products and endogenously derived molecules that have been linked to systemic and hepatic inflammation and NASH [20–23]. Here, TLR4 is linked to metabolic dysfunction-associated steatohepatitis.